PROM1 and diabetes mellitus: Thus, atorvastatin significantly increased CPCs number (CD45−CD34+CD133+) after 8–10 weeks treatment in DM patients with CVDs, however, this increase was lower and non-significant in non-DM patients with CVDs [199].